10-K Decoder · All companies

Amylyx Pharmaceuticals, Inc.

AMLX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$87.4M−100%
Operating income−$153M−$315M+51.3%
Net income−$145M−$302M+52.0%

Questions

What was Amylyx's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), −100% vs $87.4M a year earlier, per its 10-K filed Mar 2026.
Was Amylyx profitable in FY2025?
No: net income was −$145M and operating income −$153M in FY2025.